2m 2m 2m 2m 2m 2m 2m
Charles Riv Lab (CRL)
NYSE
$232.37-$0.14 (-0.06%)
Price as of Aug 03, 2026 5:48 AM EDT- $11.2BMarket Cap
- 39.30%1-Year Change
- Diagnostics & ResearchIndustry
Charles Riv Lab (CRL)
$232.37-$0.14 (-0.06%)
CRL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $232.51 | ||
Change | -$2.11 (-0.90%) | ||
Open | $235.71 | ||
High | $237.06 | ||
Low | $230.06 | ||
Previous Close | $234.62 | ||
Volume | 509,244 | ||
30-Day Average Volume | 839,488 | ||
1-Week Change | 2.62% | ||
1-Month Change | 2.52% | ||
1-Year Change | 39.30% | ||
3-Year Change | 10.96% | ||
5-Year Change | -42.86% | ||
Fundamentals | |||
Shares Outstanding | 48.2M | ||
Total Assets | $7.7B | ||
Market Cap | $11.2B | ||
Enterprise Value | $13.7B | ||
Period: QTR TTM FY | |||
Revenue | $798.2M | ||
Net Income | -$14.8M | ||
Free Cash Flow | -$14.8M | ||
EBIT | -$30.0M | ||
EBITDA | $37.2M | ||
Net Working Capital | $395.1M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | 368 | ||
Enterprise Value/Revenue | 17 | ||
P/B | 4 | ||
P/E | -775 | ||
PEG | -8 | ||
Price/Free Cash Flow | -755 | ||
Price/Operating Cash Flow | 273 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue